[go: up one dir, main page]

GB917456A - Suppository composition and preparation thereof - Google Patents

Suppository composition and preparation thereof

Info

Publication number
GB917456A
GB917456A GB36137/59A GB3613759A GB917456A GB 917456 A GB917456 A GB 917456A GB 36137/59 A GB36137/59 A GB 36137/59A GB 3613759 A GB3613759 A GB 3613759A GB 917456 A GB917456 A GB 917456A
Authority
GB
United Kingdom
Prior art keywords
acid phosphate
polyethylene glycol
carrier material
salt
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB36137/59A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CASCO LAB Inc
Original Assignee
CASCO LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CASCO LAB Inc filed Critical CASCO LAB Inc
Publication of GB917456A publication Critical patent/GB917456A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Sodium acid phosphate is heated, e.g. for 12 hours at 150 DEG C. or for 24 hours at 130 DEG C. to produce a "dehydrated sodium acid phosphate" by the reaction: <FORM:0917456/III/1> Analysis of the product indicates that it is an equilibrium mixture of sodium acid phosphate and anhydrous sodium pyrophosphate.ALSO:A suppository composition of low surface activity consists essentially of polyethylene glycol which is solid at normal temperatures (as carrier material), a salt of carbonic acid and an alkali metal acid phosphate or a dehydrated alkali metal acid phosphate or a salt of lactic, citric or tartaric acid. The suppository is preferably prepared by blending together two mixtures, one of which contains the carbonic acid salt and the carrier material and the other of which contains the carrier material and the phosphate or other reactive salt, whereby the particles of the two components of the CO2-producing couple are each enclosed in a protective film and are prevented from coming into contact until the carrier material dissolves. A preferred composition consists essentially of 15 to 44% polyethylene glycol 6000, 9 to 26% polyethylene glycol 1540, 6 to 17.4% polyethylene glycol 400, 7 to 38% sodium acid phosphate and 5 to 30% sodium bicarbonate.
GB36137/59A 1958-10-30 1959-10-26 Suppository composition and preparation thereof Expired GB917456A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77061558A 1958-10-30 1958-10-30

Publications (1)

Publication Number Publication Date
GB917456A true GB917456A (en) 1963-02-06

Family

ID=25089162

Family Applications (1)

Application Number Title Priority Date Filing Date
GB36137/59A Expired GB917456A (en) 1958-10-30 1959-10-26 Suppository composition and preparation thereof

Country Status (3)

Country Link
BE (1) BE584120A (en)
FR (1) FR316M (en)
GB (1) GB917456A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3358687A (en) * 1965-12-06 1967-12-19 Sterling Drug Inc Suppositories
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5223246A (en) * 1990-02-14 1993-06-29 Takeda Chemical Industries, Ltd. Effervescent composition, its production and use
EP0858326A4 (en) * 1996-05-08 1999-09-29 Graig A Aronchick Non-aqueous colonic purgative formulations
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
WO2010143004A3 (en) * 2009-06-10 2011-12-22 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Glycerol-free osmotic laxative suppository
IT201700054380A1 (en) * 2017-05-19 2018-11-19 Aboca Spa Societa Agricola COMPOSITIONS CONTAINING CARBON DIOXIDE RELEASE SYSTEMS OBTAINED FROM VEGETABLE JUICES
IT201900000265A1 (en) * 2019-01-09 2020-07-09 Caprika Srl "USE OF POLYETHYLENGLYCOL BY RECTAL WAY IN THE TREATMENT OF CONSTIPATION"
WO2021105792A1 (en) * 2019-11-28 2021-06-03 Caprika Srl Rectal-use composition for the treatment of constipation

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3358687A (en) * 1965-12-06 1967-12-19 Sterling Drug Inc Suppositories
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5223246A (en) * 1990-02-14 1993-06-29 Takeda Chemical Industries, Ltd. Effervescent composition, its production and use
EP0858326A4 (en) * 1996-05-08 1999-09-29 Graig A Aronchick Non-aqueous colonic purgative formulations
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
WO2010143004A3 (en) * 2009-06-10 2011-12-22 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Glycerol-free osmotic laxative suppository
EA021632B1 (en) * 2009-06-10 2015-07-30 Эгиш Дьёдьсердьяр Ньильваношан Мюкеде Ресвеньтаршашаг Glycerol-free osmotic laxative suppository and process for preparation thereof
IT201700054380A1 (en) * 2017-05-19 2018-11-19 Aboca Spa Societa Agricola COMPOSITIONS CONTAINING CARBON DIOXIDE RELEASE SYSTEMS OBTAINED FROM VEGETABLE JUICES
WO2018211372A1 (en) * 2017-05-19 2018-11-22 Aboca S.P.A Società Agricola Compositions containing systems of release of carbon dioxide obtained from plant juices
CN110650725A (en) * 2017-05-19 2020-01-03 阿波卡-阿格里科拉共同股份公司 Compositions comprising carbon dioxide release systems obtained from plant juices
US11083691B2 (en) * 2017-05-19 2021-08-10 Aboca S.P.A. Società Agricola Compositions containing systems of release of carbon dioxide obtained from plant juices
EA038832B1 (en) * 2017-05-19 2021-10-26 Абока С.П.А. Сосиета' Агрикола Compositions containing systems of release of carbon dioxide obtained from plant juices
CN110650725B (en) * 2017-05-19 2023-04-07 阿波卡-阿格里科拉共同股份公司 Composition obtained from plant juice comprising a carbon dioxide releasing system
IT201900000265A1 (en) * 2019-01-09 2020-07-09 Caprika Srl "USE OF POLYETHYLENGLYCOL BY RECTAL WAY IN THE TREATMENT OF CONSTIPATION"
WO2021105792A1 (en) * 2019-11-28 2021-06-03 Caprika Srl Rectal-use composition for the treatment of constipation

Also Published As

Publication number Publication date
FR316M (en) 1961-03-20
BE584120A (en) 1960-04-29

Similar Documents

Publication Publication Date Title
GB1359614A (en) Method for the manufacture of effervescent tablets
JPS5573662A (en) Novel hydroxyethyllazole compound*its manufacture and its use as medicine
GB917456A (en) Suppository composition and preparation thereof
ES8401960A1 (en) Imidazolylphenyl-tetrahydropyridazines, process for their preparation and pharmaceutical compositions containing them.
ES8200094A1 (en) process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives.
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
DE3068585D1 (en) Derivatives of 3,4,5-trihydroxypiperidine, processes for their preparation, and their use as medicines and in animal food
ES8103112A1 (en) Pseudotrisaccharides, their preparation and use as medicaments.
GB834972A (en) Stabilization of photographic bleach powders containing an alkali metal ferricyanide
EP0034556A3 (en) Plant-growth regulating compositions containing as active agent 2-methylene-succinamic acid derivatives, and derivatives of this acid useful in these compositions
ES8306481A1 (en) Cyclic sulfenamides, process for their preparation, medicines containing them and preparation of the latter.
GB1287084A (en) Benzimidazole derivatives, process for their preparation, and their fungicidal use
GB844445A (en) Dry fire-extinguishing powders
GB882567A (en) Improvements in or relating to the stabilization of dichloralphenazone
GB765619A (en) Improvements relating to the drying of bird manure
ES8600768A1 (en) Aminoalkyl-imidazothiadiazolecarboxamides, intermediates for their preparation, their preparation and their use as medicaments.
GB848345A (en) Production of beryllium flouride
JPS55137035A (en) Composition of novel emulsifying agent and improving method for quality of starches
BE587681A (en) Therapeutic compositions of interest as antihypertensive agents and methods of preparation
CA515169A (en) Preparation of product containing sodium acid cyanamide
ES371027A2 (en) Procedure for the electrostatic preparation of raw salts from the potassa industry, in particular of carnalite salts or even from residues. (Machine-translation by Google Translate, not legally binding)
ES411834A3 (en) A method of preparation of titranolide of titanium. (Machine-translation by Google Translate, not legally binding)
GB728688A (en) Process for the stabilisation of adenosine polyphosphoric acids
BE611259A (en) Process for the preparation of dust-free crystallized zinc chloride, and product obtained
ES211601A1 (en) A procedure for the preparation of a hierbicide compound (Machine-translation by Google Translate, not legally binding)